to the investor
IN THE MEDIA
Cannabics Pharmaceuticals Inc. Receives the Final Report of Its Research on Antitumor Properties of Cannabinoids Held in Israel.
Cannabics Pharmaceuticals Inc. Appoints New Members to its Board of Advisors.
Cannabics Pharmaceuticals Inc. Provides Shareholders Update Regarding Increased Volume in its Shares.